NCT03341377View on ClinicalTrials.gov

Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)

CompletedOBSERVATIONAL
Enrollment

512

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

January 1, 2020

Conditions
Patient-reported Outcomes
Trial Locations (6)

610041

Sichuan Cancer Hospital and Research Institute, Chengdu

621700

Jiangyou People's Hospital, Jiangyou

643000

Zigong First People's Hospital, Zigong

Unknown

Chengdu Seventh People's Hospital, Chengdu

Chengdu Third People's Hospital, Chengdu

Dazhu County People's Hospital, Dazhou

All Listed Sponsors
collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Sichuan Cancer Hospital and Research Institute

OTHER

collaborator

Zigong No.1 Peoples Hospital

OTHER

collaborator

Jiangyou People's Hospital

UNKNOWN

collaborator

Chengdu Third People's Hospital

UNKNOWN

collaborator

Chengdu Seventh People's Hospital

UNKNOWN

collaborator

Dazhu County People's Hospital

UNKNOWN

lead

Xiaojun Yang

OTHER

NCT03341377 - Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1) | Biotech Hunter | Biotech Hunter